All In MedTech

Device Trial Radar · NCT07922187

Speech Recognition With Hearing Enhancement

Characterization of Speech Recognition in Noise With Hearing Enhancement

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

43

Actual

Start

Oct 20, 2026

Primary completion

Oct 28, 2026

Study completion Oct 28, 2026

Sponsor

Lead sponsor
Meta Platforms Technologies LLCNot on our public-company list
Sponsor type
Industry
Collaborators
Exponent, Inc.
First posted
Nov 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Speech Recognition with Hearing Enhancement in Background Noise

Conditions

  • Hearing

Interventions

  • Hearing EnhancementDevice

    Hearing Enhancement is an FDA-cleared (K254044), over-the-counter, self-fitting, air-conduction hearing aid software (SaMD) that runs on Meta smart glasses with a companion smartphone app. Participants complete the in-app self-fitting procedure, and the app programs personalized amplification settings to the glasses. Hearing Enhancement is enabled with the participant's self-fit settings (aided) and is compared with the same glasses worn with Hearing Enhancement turned off (unaided).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. BenefitTime frame: Visit 2, a single test session, within 2 weeks of the screening visit)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Exponent

    Menlo Park, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.